Price War Accelerates After Novo Nordisk Launches Oral Wegovy

Novo Nordisk launched its oral weight-loss drug Wegovy in the USA on January 5, 2026, triggering an immediate price war.The daily pill is priced between $149 and $299 per month, making it significantly cheaper than injectable versions that often cost over $1,000.Manufacturing facilities in North Carolina are operating at maximum capacity as the company seeks to regain market share from its rival Eli Lilly.